| INMED PHARMACEUTICALS |
| Kanada |
| Gesundheit |
| CA4576377002 / A40UCN |
| MWG (Frankfurt) / INM (NASDAQ) |
| FRA:MWG, ETR:MWG, MWG:GR, NASDAQ:INM |
| - |
| https://www.inmedpharma.c.. |
|
InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company based in Vancouver, Canada, focused on developing proprietary small molecule therapeutics targeting the CB1 and CB2 receptors. The company concentrates on diseases with high unmet ..
>Volltext.. |
| 4.4 Mio. EUR |
| 0.22 Mio. EUR |
| 2.84 Mio. EUR |
| -6.96 Mio. EUR |
| -7.44 Mio. EUR |
| -2.25 EUR |
| 0.37 Mio. EUR |
| 4.51 Mio. EUR |
| -6.74 Mio. EUR |
| 2.35 |
| -34.06% |
| -2.39% |
| - |
| - |
| - |
| INMED |
| 19.07.26 |
|